| [1] | Mitchison DA (1998) How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 2: 10–15.
|
| [2] | Zellweger JP, Coulon P (1998) Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 2: 372–377.
|
| [3] | Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, et al. (1997) Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 111: 1168–1173.
|
| [4] | Thomas C (2002) A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy. J Manag Med 16: 371–400.
|
| [5] | Kassim S, Sassam-Morokro M, Akhan A, Abouya LY, Digbeu H, et al. (1995) Two-year follow-up of persons with HIV-1 and HIV-2-associated pulmonary tuberculosis treated with short-course in West Africa. AIDS 9: 1185–1191.
|
| [6] | Kazeonny B, Khorosheva T, Aptekar T, Rybka L, Kluge H, et al. (2001) Evaluation of directly observed therapy short course strategy for treating tuberculosis-Orel Oblast, Russian Federation, 1999–2000. MMWR 50: 204–206.
|
| [7] | Zhang L-X, Tu DH, Enarson DA (2000) The impact of directly observed treatment on the epidemiology of tuberculosis in Beijing. Int J Tuberc Lung Dis 4: 904–910.
|
| [8] | Volmink J, Garner P (2001) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 4: CD003343.
|
| [9] | Wally JD, Khan MA, Newell JN, Khan MH (2001) Effectiveness of the direct observation component of DOTS for tuberculosis: A randomised controlled trial in Pakistan. Lancet 357: 664–669.
|
| [10] | Squire SB, Wilkinson D (1997) Strengthening “DOTS” through community care for tuberculosis. BMJ 315: 1395–1396.
|
| [11] | Volmink J, Garner P (1997) Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 315: 1403–1406.
|
| [12] | Volmink J, Garner P (2000) Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 4: CD000010.
|
| [13] | Sanou A, Dembele M, Theobald S, Macq J (2004) Access and adhering to tuberculosis treatment: Barriers faced by patients and communities in Burkina Faso. Int J Tuberc Lung Dis 8: 1479–1483.
|
| [14] | Jaiswal A, Singh V, Ogden JA, Porter JD, Sharma PP, et al. (2003) Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India. Trop Med Int Health 8: 625–633.
|
| [15] | World Health Organization (2005) Global tuberculosis control: Surveillance, planning, financing. WHO Report 2005. Publication WHO/HTM/TB/2005.349. Geneva: World Health Organization. 258 p.
|
| [16] | Demissie M, Kebede D (1994) Defaulting from tuberculosis treatment at the Addis Ababa Tuberculosis Centre and factors associated with it. Ethiop Med J 32: 97–106.
|
| [17] | Tekle B, Mariam DH, Ali A (2002) Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis 6: 573–579.
|
| [18] | Shargie EB, Lindtjorn B (2005) DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: A retrospective trend analysis. BMC Public Health 5: 62.
|
| [19] | Ministry of Health of Ethiopia (2002) Tuberculosis and leprosy control programme manual. 2nd edition. Addis Ababa: Ministry of Health of Ethiopia. 122 p.
|
| [20] | Nuwaha F (1997) Factors influencing completion of treatment among tuberculosis patients in Mbarara District, Uganda. East Afr Med J 74: 690–693.
|
| [21] | Kaona FA, Tuba M, Siziya S, Sikaona L (2004) An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 4: 68.
|
| [22] | Nuwaha F (1999) Control of tuberculosis in Uganda: A tale of two districts. Int J Tuberc Lung Dis 3: 224–230.
|
| [23] | Comolet TM, Rakotomalala R, Rajaonarioa H (1998) Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis 2: 891–897.
|
| [24] | Salles CL, Conde MB, Hofer C, Cunha AJ, Calcada AL, et al. (2004) Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 8: 318–322.
|
| [25] | Chang KC, Leung CC, Tam CM (2004) Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 8: 1492–1498.
|
| [26] | Southern Nations Nationalities and Peoples' Regional State Health Bureau (2003) The health sector development plan: PhaseII (2003–2005). Awassa, Ethiopia: Southern Nations Nationalities and Peoples' Regional State Health Bureau. 139 p.
|
| [27] | Getahun H, Maher D (2000) Contribution of “TB clubs” to tuberculosis control in a rural district in Ethiopia. Int J Tuberc Lung Dis 4: 174–178.
|
| [28] | Demissie M, Getahun H, Lindtjorn B (2003) Community tuberculosis care through “TB clubs” in rural North Ethiopia. Soc Sci Med 56: 2009–2018.
|
| [29] | Federal Ministry of Health (2005) Health sector strategic plan: HSDP-III (2006–2010) Addis Ababa: Planning and Programming Department, Federal Ministry of Health. 143 p.
|
| [30] | Jinadani A, Nunn AJ, Enarson DA (2004) Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: International multicentre randomised trial. Lancet 364: 1244–1251.
|
